Trials / Unknown
UnknownNCT05452434
Mirabegron Combined With Behavioral Intervention for Overactive Bladder：a Prospective Multicenter Randomized Controlled Clinical Study
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 600 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- Female
- Age
- 40 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to assess the efficacy, safety and tolerability of Mirabegron and behavioral combination versus Mirabegron alone in the treatment of women with overactive bladder (OAB）.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | mirabegron | mirabegron 50mg QD for 12 weeks. |
Timeline
- Start date
- 2022-07-15
- Primary completion
- 2023-07-15
- Completion
- 2023-07-15
- First posted
- 2022-07-11
- Last updated
- 2022-07-11
Source: ClinicalTrials.gov record NCT05452434. Inclusion in this directory is not an endorsement.